Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure

Autor: Degasperi, Elisabetta 1, ⁎, Spinetti, Angiola 2, Lombardi, Andrea 3, Landonio, Simona 4, Rossi, Maria Cristina 5, Pasulo, Luisa 6, Pozzoni, Pietro 7, Giorgini, Alessia 8, Fabris, Paolo 9, Romano, Antonietta 10, Lomonaco, Lorenzo 11, Puoti, Massimo 12, Vinci, Maria 13, Gatti, Federico 14, Carolo, Giada 15, Zoncada, Alessia 16, Bonfanti, Paolo 17, Russo, Francesco Paolo 18, Aghemo, Alessio 19, Soria, Alessandro 20, Centenaro, Riccardo 21, Maggiolo, Franco 6, Rovere, Pierangelo 22, Pasin, Francesca 23, Paon, Veronica 24, Faggiano, Giovanni 25, Vario, Alessandro 26, Grossi, Glenda 27, Soffredini, Roberta 1, Carriero, Canio 2, Paolucci, Stefania 28, Noventa, Franco 29, Alberti, Alfredo 23, Lampertico, Pietro 1, Fagiuoli, Stefano 6
Zdroj: In Journal of Hepatology December 2019 71(6):1106-1115
Databáze: ScienceDirect
Externí odkaz: